Literature DB >> 7507904

Oxygen-induced retinopathy in the mouse.

L E Smith1, E Wesolowski, A McLellan, S K Kostyk, R D'Amato, R Sullivan, P A D'Amore.   

Abstract

PURPOSE: To develop oxygen-induced retinopathy in the mouse with reproducible and quantifiable proliferative retinal neovascularization suitable for examining pathogenesis and therapeutic intervention for retinal neovascularization in retinopathy of prematurity (ROP) and other vasculopathologies.
METHODS: One-week-old C57BL/6J mice were exposed to 75% oxygen for 5 days and then to room air. A novel fluorescein-dextran perfusion method has been developed to assess the vascular pattern. The proliferative neovascular response was quantified by counting the nuclei of new vessels extending from the retina into the vitreous in 6 microns sagittal cross-sections. Cross-sections were also stained for glial fibrillary acidic protein (GFAP).
RESULTS: Fluorescein-dextran angiography delineated the entire vascular pattern, including neovascular tufts in flat-mounted retinas. Hyperoxia-induced neovascularization occurred at the junction between the vascularized and avascular retina in the mid-periphery. Retinal neovascularization occurred in all the pups between postnatal day 17 and postnatal day 21. There was a mean of 89 neovascular nuclei per cross-section of 9 eyes in hyperoxia compared to less than 1 nucleus per cross-section of 8 eyes in the normoxia control (P < 0.0001). Proliferative vessels were not associated with GFAP-positive astrocyte processes.
CONCLUSIONS: The authors have described a reproducible and quantifiable mouse model of oxygen-induced retinal neovascularization that should prove useful for the study of pathogenesis of retinal neovascularization as well as for the study of medical intervention for ROP and other retinal angiopathies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507904

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  690 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  More weapons in the arsenal against ischemic retinopathy.

Authors:  E Keshet
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  PEDF: Raising both hopes and questions in controlling angiogenesis.

Authors:  G J Chader
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 4.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

5.  Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.

Authors:  Steven J Budd; M Elizabeth Hartnett
Journal:  Arch Ophthalmol       Date:  2010-05

6.  Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye.

Authors:  Irina Semkova; Florian Kreppel; Gerhard Welsandt; Thomas Luther; Jolanta Kozlowski; Hanna Janicki; Stefan Kochanek; Ulrich Schraermeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

7.  Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy.

Authors:  Lian Zhao; Wenxin Ma; Robert N Fariss; Wai T Wong
Journal:  Exp Eye Res       Date:  2009-01-07       Impact factor: 3.467

8.  Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.

Authors:  Michael H Davies; David O Zamora; Justine R Smith; Michael R Powers
Journal:  Microvasc Res       Date:  2009-02-13       Impact factor: 3.514

9.  NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation.

Authors:  Wenbo Zhang; Modesto Rojas; Brenda Lilly; Nai-Tse Tsai; Tahira Lemtalsi; Gregory I Liou; Robert W Caldwell; Ruth B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

10.  Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.

Authors:  Athanasia Skoura; Teresa Sanchez; Kevin Claffey; Suzanne M Mandala; Richard L Proia; Timothy Hla
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.